Clinical Trials Browser

Phase EARLY_PHASE1 × Immunotherapy × 90 days × Clear all

NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT07017816 2026-04-29

JACOB

Phase EARLY_PHASE1 Recruiting

Neoplasms, Germ Cell and Embryonal, Pinealoma, Central Nervous System Neoplasms